Loading

This agenda is still in development. All sessions and timings are subject to regular change at this time. 

Investment Summit
    • Investment Summit
    Indigo Ballroom, Hilton Bayfront Hotel
    • Investment Summit
    Indigo Ballroom, Hilton Bayfront Hotel

    Gain a data-driven outlook on the current state of cell and gene therapy (CGT) investment. This keynote explores emerging trends, evolving investor priorities, and why early-stage innovation remains essential to sustaining industry growth.

    • Investment Summit
    Indigo Ballroom, Hilton Bayfront Hotel
    As capital deployment becomes more selective, understanding investor expectations is essential for biotech leaders seeking funding. This discussion brings together leading VCs to dissect how decision criteria have evolved, what defines a “fundable” company in 2026, and how scientific, regulatory, and commercial factors intersect to shape valuation and deal momentum.
    • Investment Summit
    Indigo Ballroom, Hilton Bayfront Hotel

    The road from concept to growth-stage financing is rarely straightforward. In this in-depth spotlight session, a biotech founder shares first-hand lessons from navigating multiple funding rounds, balancing scientific proof-of-concept with investor readiness, and leveraging non-dilutive opportunities along the way. Attendees will gain a practical view of how to build traction and credibility in a cautious capital market.

    • Investment Summit
    Indigo Ballroom, Hilton Bayfront Hotel
    • Investment Summit
    Indigo Ballroom, Hilton Bayfront Hotel

    After two years of market stagnation, the CGT investment landscape is slowly recalibrating. Investors are using this reset to reassess portfolios, strengthen fundamentals, and prepare for the next cycle of growth. This session will unpack how strategic investors are managing capital constraints, supporting existing assets, and driving long term opportunity.

    • Investment Summit
    Indigo Ballroom, Hilton Bayfront Hotel

    As investors recalibrate their strategies in the CGT sector, attention is shifting beyond therapeutic developers to the tools, platforms and enabling technologies that underpin the industry. These companies spanning automation, analytics and manufacturing systems are becoming the backbone of CGT progress. In this fireside chat, explore how investors are identifying value in the infrastructure layer of advanced therapies, and why tools and tech providers may be an opportunity for long-term growth.

    • Investment Summit
    Networking break
    Indigo Ballroom, Hilton Bayfront Hotel
    • Investment Summit
    Indigo Ballroom, Hilton Bayfront Hotel

    During the current market stabilisation, investors are rethinking what “safe” looks like in a high-risk, high-reward industry. This data-driven session will unpack the latest capital flow trends – from tools and platforms to therapeutic developers- and reveal how investor priorities are evolving. Attendees will gain a snapshot of where capital is being deployed, which business models are attracting confidence, and how risk appetite is shifting as the market evolves.

    • Investment Summit
    Indigo Ballroom, Hilton Bayfront Hotel

    This fireside chat will explore how leading venture and growth investors are adapting their strategies and balancing short-term caution with long-term conviction. From diversification to value creation, uncover what smart, sustainable investment looks like in today’s CGT market

    • Investment Summit
    Indigo Ballroom, Hilton Bayfront Hotel
    While scientific innovation drives breakthroughs in CGT, commercial understanding often determines whether those breakthroughs reach patients – and investors. This session will unpack why strong commercial acumen is just as critical as scientific excellence in securing funding and scaling successfully. Industry leaders and investors will discuss what scientific founders need to know about pricing, reimbursement, and market access, and how early commercial strategy can turn cutting-edge research into investable, sustainable businesses.
    • Investment Summit
    Indigo Ballroom, Hilton Bayfront Hotel
    Investment in cell and gene therapies (CGT) is increasingly global, with innovation hubs expanding beyond traditional markets. This discussion brings together leading investors to examine where value is emerging, how to evaluate cross-border opportunities, and what factors differentiate regions building sustainable biotech ecosystems. For US-based investors, the conversation extends to assessing global competitiveness, risk management, and long-term growth potential.
    • Investment Summit
    Indigo Ballroom, Hilton Bayfront Hotel
    Building effective co-investment partnerships and syndicate structures Balancing collaboration with competitive differentiation How to share diligence, deal flow, and exit strategies transparently and ...
    • Investment Summit
    Indigo Ballroom, Hilton Bayfront Hotel
    Which enabling tools and tech are most critical to long-term CGT scalability How investors are balancing exposure between tools, services and therapeutics
Founders Forum
    • Founders Forum
    Room A
    Turn a good deck into a compelling case. Rapid, focused reviews reveal what hooks investors and what to cut.
    • Founders Forum
    Room A
    Build under pressure, not despite it. Secure capital, fortify your team, and make crisp decisions that keep growth compounding when resources are thin.
    • Founders Forum
    Room A
    Learn how to transform strategy into execution by building the operational backbone for sustainable growth. Discover the systems, processes, and culture that enable biotech startups to scale with precision and resilience. 
    • Founders Forum
    Room A
    Explore how to position your biotech for sustained strategic success beyond early funding rounds. Learn to build partnerships, enhance commercial readiness, and plan long-term trajectories that accelerate growth and impact. 
Women in Advanced Therapies Congress
    • Women in Advanced Therapies Congress
    Room D
    From boardroom influence to everyday allyship, hear how women in CGT break barriers and build pipelines of talent. Leave with plays for mentorship, sponsorship, and momentum
    • Women in Advanced Therapies Congress
    Room D
    Learn how to create inclusive workplace cultures and equitable policies that drive measurable impact. Explore strategies to address unconscious bias, close representation gaps, and sustain long-term diversity, equity, and inclusivity (DEI) initiatives.
    • Women in Advanced Therapies Congress
    Room D
    Explore how mentorship can shape leadership journeys and foster inclusive career development. Learn strategies to empower emerging talent and strengthen workplace culture in male-dominated industries. 
    • Women in Advanced Therapies Congress
    Room D
    Discover strategies to address disparities in women’s health research, clinical trials, and access to care. Learn how policy, advocacy, and industry engagement can advance equity in health outcomes. 
    • Women in Advanced Therapies Congress
    Room D
    Explore how to build, maintain and leverage networks and mentorships to advance careers and influence your industry. 
    • Women in Advanced Therapies Congress
    Room D
    Share approaches to recognise and overcome self-doubt while thriving in male-dominate spaces. 
    • Women in Advanced Therapies Congress
    Room D
    Discuss how empathy, intuition and people skills can be leveraged as leadership strengths. 
    • Women in Advanced Therapies Congress
    Room D
    Examine actionable steps to advance women into executive and board-level positions. 
    • Women in Advanced Therapies Congress
    Room D
    Explore strategies for securing funding, support and recognition for women-led initiatives. 
    • Women in Advanced Therapies Congress
    Room D
    Discuss realistic ways to prioritise well-being while pursuing career success. 
    • Women in Advanced Therapies Congress
    Room D
    Explore strategies to close gaps in research, clinical trials and healthcare access for women 
    • Women in Advanced Therapies Congress
    Room D
    Share experiences of unconventional career trajectories and how they can create leadership opportunities. 
    • Women in Advanced Therapies Congress
    Room D
    Discuss how collaboration and mentorship can foster a supportive and empowering environment. 
    • Women in Advanced Therapies Congress
    Room D
    Examine strategies for engaging everyone in advancing gender equality. 
    • Women in Advanced Therapies Congress
    Room D
    To be confirmed
    Emerson
    • Women in Advanced Therapies Congress
    Room D
    To be confirmed
    Assurea
Plenary
    • Plenary
    Indigo Ballroom, Hilton Bayfront Hotel
    The opening Superplenary gathers the CGT world to chart what is next: access, regulation, scale, and real patient impact. Set your strategy for the week with the signals that will define 2026 and beyond.
Networking
    • Networking
    Mentor & networking hour
    Indigo Ballroom, Hilton Bayfront Hotel
    • Networking
    San Diego, Wine & Culinary Center
    Kick off Advanced Therapies Week in style at Sip & Connect, the official welcome party that blends great food, fine wine, and meaningful conversation.
Event Logistics
    • Event Logistics
    Badge collection
    Hilton San Diego Bayfront

    Badge collection will be available from the event registration desk at the Hilton Bayfront Hotel.

    Starting at 9am.

    • Event Logistics
    Badge collection
    San Diego Convention Center

    Badge collection will be available from the event registration desk at the San Diego Convention Center.

    Starting at 2pm.

Manufacturing & Supply
    • Manufacturing & Supply
    Theatre 1
    Make automation your force multiplier for CGT manufacturing. Faster, more consistent batches with real-time oversight and smarter integration.
    • Manufacturing & Supply
    Theatre 1
    • Manufacturing & Supply
    Lunch & exhibition time
    • Manufacturing & Supply
    Theatre 1
    Make tech transfer frictionless as you grow. Lock in robust processes, nail GMP handoffs, and scale with fewer surprises.
    • Manufacturing & Supply
    Theatre 1
    Turn tech transfer into a growth engine: move from lab to line faster with reproducible runs, fewer bottlenecks, and GMP-ready discipline.
    • Manufacturing & Supply
    Theatre 1
    Turn GMP sourcing into a strength, not a risk. Secure critical inputs, squeeze out bottlenecks, and build a supply chain that scales on schedule.
    • Manufacturing & Supply
    Theatre 1
    • Manufacturing & Supply
    Theatre 1
    Turn allogeneic therapies into true off-the-shelf products. Standardise, scale, and safeguard quality from first lots to full commercial supply.
    • Manufacturing & Supply
    Theatre 1
    Can HLA matching unlock durability for off-the-shelf cells? Pull the levers that extend persistence, boost potency, and raise response rates.
    • Manufacturing & Supply
    Theatre 1
    Pick the model that wins on speed, scale, and spend. Autologous vs allogeneic, we unpack closed-system automation, vein-to-vein logistics, and the standardization that unlocks throughput.
    • Manufacturing & Supply
    Theatre 1
    Execution roadmap to automation and an enhanced analytical control strategy
Clinical Development & Translation
    • Clinical Development & Translation
    Theatre 2
    This fireside chat examines strategies to improve the predictive value of preclinical models for human outcomes. Discussion will focus on trial design, early human data, and integrated frameworks to de-risk early clinical programs.
    • Clinical Development & Translation
    Theatre 2
    Route, dose, and monitor with confidence. Practical tactics to reach the right cells, manage adverse events, and execute lean trials in small populations.
    • Clinical Development & Translation
    Theatre 2
    Bridge IND to bedside with operational discipline, smart site selection, patient-first recruitment, and early regulatory prep that keeps timelines moving.
    • Clinical Development & Translation
    Lunch & exhibition time
    • Clinical Development & Translation
    Theatre 2

    Make regulators your early partner, not a gatekeeper. Tight submissions and clear trial plans turn uncertainty into predictable timelines.

     

    • Clinical Development & Translation
    Theatre 2
    From first patients to first proof, watch what happens when heterogeneity meets trial design. Practical lessons to lift fidelity, safety, and enrolment
    • Clinical Development & Translation
    Theatre 2

    Turn patient voice into regulatory momentum. Co-create protocols, sharpen endpoints, and move first in human sooner.

     

    • Clinical Development & Translation
    Theatre 2
    Choose endpoints that truly matter to patients and regulators, built to be measurable, meaningful, and defensible in small, variable cohorts.
    • Clinical Development & Translation
    Theatre 2
    Endpoints that matter to patients and regulators alike: design for relevance, validate smartly, and report with confidence.
    • Clinical Development & Translation
    Theatre 2
    From start-up to closeout, perfect the sponsor-site handshake. Clear workflows, crisp communication, faster trials.
    • Clinical Development & Translation
    Theatre 2
    Cross the last mile from clinic to market with confidence. Lock launch readiness across manufacturing, quality, and regulatory while de-risking supply at scale.
    • Clinical Development & Translation
    Theatre 2
    Turn discovery into first in human momentum. Build the preclinical, analytical, and regulatory engine that carries your lead straight into clinic.
Emerging Modalities & Innovation
    • Emerging Modalities & Innovation
    Lunch & exhibition time
    • Emerging Modalities & Innovation
    Theatre 3
    Turn AI into your CGT R&D edge. Cut cycle time, tighten biomarker calls, and move from model to patient with confidence.
    • Emerging Modalities & Innovation
    Theatre 3
    Take CGT beyond oncology into autoimmune and neuro with confidence. Tailor trial design, sharpen biomarkers, and safeguard long-term safety for chronic, complex disease.
    • Emerging Modalities & Innovation
    Theatre 3
    Unlock the next wave of CGT with platforms that cut cycle time, scale cleanly, and lift your hit rate from model to patient.
    • Emerging Modalities & Innovation
    Theatre 3
    Beat the tumor microenvironment at its own game. Pick modalities that penetrate, dose cleanly, and keep signals meaningful from preclinical to patient.
    • Emerging Modalities & Innovation
    Theatre 3
    Turn iPSCs into therapies at scale. Engineer repeatable manufacturing, rigorous QC, and clinical relevance regulators can back.
    • Emerging Modalities & Innovation
    Theatre 3

    Rethink your starting material to beat scale and persistence bottlenecks while boosting translational fidelity. Practical moves for safety, biomarkers, and approval readiness.

    • Emerging Modalities & Innovation
    Theatre 3
    Skip personalized manufacturing. A branched polypeptide ferries mcDNA in vivo to arm diverse immune cells, opening a scalable path to CAR activity in solid tumors.
    • Emerging Modalities & Innovation
    Theatre 3
    Skip the ex vivo bottlenecks with in vivo engineering. Balance potency, safety, and trial design to bring cell therapy to more patients.
Growth & Investment
    • Growth & Investment
    Theatre 4
    What wins now for investors and developers alike: crisp clinical signals, efficient trial design, and funding that maps to risk. Build a plan that survives scrutiny.
    • Growth & Investment
    Theatre 4
    From launch to longevity, design commercial frameworks that fit CGT’s realities. Think value-based contracts, smarter distribution, and proof that endures.
    • Growth & Investment
    Lunch & exhibition time
    • Growth & Investment
    Theatre 4
    • Make academia and industry collaborations actually deliver: align incentives, lock in IP, set crisp governance, and blend funding to carry breakthroughs from bench to bedside.

    •  

    • Growth & Investment
    Theatre 4

    Win capital for CGT in a tight market. Pair smart de-risking with deal structures that stretch runway and keep programs moving.

Phacilitate.TV
    • Phacilitate.TV
    Phacilitate.TV Studio

    Showcase your story on Phacilitate.TV. Filming slots are limited, and the schedule will be posted here soon.

    Book a Filming Slot

Workshop
    • Workshop
    Theatre 3
    • Workshop
    Theatre 2
    • Workshop
    Lunch & exhibition time
    • Workshop
    Theatre 3
    • Workshop
    Theatre 2
    • Workshop
    Theatre 3
    • Workshop
    Theatre 2
Networking
    • Networking
    Petco Park takeover
    Petco Park Stadium
    For one night only, Phacilitate takes over San Diego’s iconic Petco Park. This is networking on a grand scale, with food, drinks, and panoramic views of the city skyline. With drinks, canapés & entertainment, it will be the biggest night of the week, where biotech leaders, investors, and solution providers come together.  
Event Logistics
    • Event Logistics
    Exhibition hall opens
    San Diego Convention Center
    • Event Logistics
    Lunch & exhibition time
    • Event Logistics
    Networking & exhibition time
Manufacturing & Supply
    • Manufacturing & Supply
    Theatre 1
    Make new modalities manufacturable at scale. Lock quality early, align CMC with regulators, and design delivery that holds up in the real world.
    • Manufacturing & Supply
    Theatre 1
    • Manufacturing & Supply
    Theatre 1

    Can decentralised and point of care models deliver speed without sacrificing quality or cost control? See how digital tools, modular sites, and closed systems make local manufacturing scale.

     

    • Manufacturing & Supply
    Lunch & exhibition time
    • Manufacturing & Supply
    Theatre 1
    Unlock wider access with decentralized delivery that still runs tight. Equip hospitals, harden cold chain, and keep traceability airtight so patients get treated faster.
    • Manufacturing & Supply
    Theatre 1
    Move from pilot to commercial with confidence. Standardize testing, control drift, and prove consistency across sites and timelines.
    • Manufacturing & Supply
    Theatre 1
    Replication-competent AAVs (rcAAV) are gene therapy product-related impurities that could have associated safety risks for patients. rcAAVs are conventionally detected in cell-based assays consisting ...
    • Manufacturing & Supply
    Theatre 1
    Through a collaboration with a university and hospital, our Optima team has developed a machine for decentralized and centralized automated production of an Advanced Therapy Medicinal Product (ATMP). ...
    • Manufacturing & Supply
    Theatre 1

    From apheresis to infusion, align operations with manufacturing and delivery so every handoff is clean and compliant. Build capacity with robust training and end-to-end traceability.

     

    • Manufacturing & Supply
    Theatre 1
    Turn your CDMO into a scale engine for CGT. Speed tech transfer, standardise quality, and compress time to clinic and launch.
    • Manufacturing & Supply
    Theatre 1
    CDMO or in house? Compare time to market, flexibility, and compliance to shape a strategy that grows with your pipeline.
    • Manufacturing & Supply
    Theatre 1
    This panel explores strategies for designing robust analytical and quality control frameworks in cell and gene therapy manufacturing.
Clinical Development & Translation
    • Clinical Development & Translation
    Lunch & exhibition time
    • Clinical Development & Translation
    Theatre 2
    Smarter studies for rare and underserved groups that fuse modern endpoints with proactive agency dialogue to keep approvals on track.
    • Clinical Development & Translation
    Theatre 2
    Find the few, fast. Pinpoint rare disease patients, clear logistical hurdles, and turn advocacy into enrollment momentum.
    • Clinical Development & Translation
    Theatre 2
    Power CGT trials with biomarkers and companion diagnostics that enrich the right patients and lift your signal to noise. Build regulatory grade readouts that speed decisions and de-risk development.
    • Clinical Development & Translation
    Theatre 2
    Turn an early program into a green light with predictive models, fit for purpose biomarkers, and a protocol built for speed and scale.
Emerging Modalities & Innovation
    • Emerging Modalities & Innovation
    Theatre 3
    Turn patient voice into better science and better outcomes. Align design, safety margins, and pricing with what people value most.
    • Emerging Modalities & Innovation
    Lunch & exhibition time
    • Emerging Modalities & Innovation
    Theatre 3

    Push gene editing forward without tripping on the rulebook. Nail safety signals, tame off targets, and build a compliance trail regulators trust.

    • Emerging Modalities & Innovation
    Theatre 3
    • Emerging Modalities & Innovation
    Theatre 3
    Adopt smarter, not slower. A practical playbook to evaluate, de-risk, and embed new platforms so innovation shows up in your data and timelines.
    • Emerging Modalities & Innovation
    Theatre 3
    Turn allo into access at scale; lock consistency with robust QC, de-risk immunogenicity, and carry data from model to patient.
    • Emerging Modalities & Innovation
    Theatre 3
    Build a supply chain that makes off-the-shelf therapies truly on demand. Harden cold chain, tighten QA, and deliver globally with speed and certainty.
Regulation & Access
    • Regulation & Access
    Theatre 4
    Unlock global access for advanced therapies. Harmonise approvals, align reimbursement, and build delivery pathways that get treatments to patients faster.
    • Regulation & Access
    Theatre 4
    Crack CGT reimbursement with durable value, smart risk sharing, and pricing that opens access without blowing budgets.
    • Regulation & Access
    Lunch & exhibition time
Phacilitate.TV
    • Phacilitate.TV
    Phacilitate.TV Studio

    Showcase your story on Phacilitate.TV. Filming slots are limited, and the schedule will be posted here soon.

    Book a Filming Slot

Workshop
    • Workshop
    Theatre 3
    • Workshop
    Theatre 2
    • Workshop
    Lunch & exhibition time
    • Workshop
    Theatre 3
    • Workshop
    Theatre 2
    • Workshop
    Theatre 3
Networking
    • Networking
    Phacilitate run club
    Hilton San Diego Bayfront
    Kickstart your day with a refreshing 5k run alongside fellow attendees. 
    • Networking
    San Diego Convention Center

    When the sessions finish, the networking continues! Open to all ticket holders and free to attend, the Exhibition Party takes place on the show floor with a mix of bars, a DJ, and a few fun surprises. It is the perfect way to carry on conversations, make new connections, and enjoy the evening with the community.

Event Logistics
    • Event Logistics
    Exhibition hall opens
    San Diego Convention Center
    • Event Logistics
    Lunch & exhibition time
    • Event Logistics
    Networking & exhibition time
    • Event Logistics
    Topgolf
    Marriot Marquid San Diego
    Invite only
Special Interest Groups
    • Special Interest Groups
    Theatre 1
    The Automation SIG unites experts from biopharma, technology, contract manufacturing, and academia to accelerate automation in cell and gene therapy (CGT) manufacturing, focusing on closed-system processing, digital integration, and workforce considerations to improve efficiency, consistency, and scalability.
    • Special Interest Groups
    Theatre 2
    The Data Standardization & Implementation SIG brings together experts from biopharma, manufacturing, regulatory, informatics, and technology to advance harmonized data standards in cell and gene therapy (CGT), enabling scalable digital transformation and the ethical application of AI and machine learning.
    • Special Interest Groups
    Theatre 3
    The Decentralized Manufacturing SIG unites stakeholders to explore scalable, resilient, and accessible models for cell therapy production. This group focuses on regulatory, technological, and quality challenges to advance collaborative, practical approaches worldwide.
    • Special Interest Groups
    Theatre 4

    The Blood Centers SIG unites leaders from blood centers, blood banks, and collection networks within the broader CGT community to address challenges

    and opportunities in CGT development, manufacturing, and delivery, focusing on strategies to enhance equitable access and operational readiness.

Networking
    • Networking
    SIG networking event
    Dedicated networking event for the Special Interest Groups - more info to come soon! 
Event Logistics
    • Event Logistics
    San Diego Convention Center